One sentence summary: Phages and antibiotics are likely to interact in natural and clinical contexts. We show that the impact of antibiotics on phages is time-dependent but that combination therapies have great potential.
INTRODUCTION
Bacteriophages, or phages, the viruses of bacteria, contribute to shaping microbial communities in most ecosystems (Weinbauer and Rassoulzadegan 2004; Mills et al. 2013; Obeng, Pratama and Elsas 2016) . Research on phages is highly diverse, including the structure of phage proteins, their genome, evolutionary potential and therapeutic applications. An underexplored issue is the potential impacts of antibiotics on phages. Most antibiotics employed in the clinic have an environmental origin, derived from natural microbiological warfare (Martínez 2008; Allen et al. 2010) . As phages are ubiquitous in nature, they are likely to interact with antibiotics in natural contexts. Obtaining a better understanding of how antibiotics affect phages is important given the potential of combined phage-antibiotic therapies in counteracting antibiotic-resistant bacteria (e.g. Torres-Barceló and Hochberg 2016) .
Both in therapeutic and natural contexts, bacteria face the presence of antibiotics with important short and long-term consequences on them (Rizzo et al. 2013) . For example, antibiotics increase mortality in sensitive bacterial populations, select for resistant variants, affect bacterial fitness and may even impose trade-offs involving important physiological capacities in surviving bacteria (e.g. Roux et al. 2015; Knudsen et al. 2016) . Even low (sub-lethal) concentrations of antibiotics have been shown to select for resistance and increase mutation rates in bacterial populations (Andersson and Hughes 2014) . Given these effects on bacteria, indirect effects of antibiotics on phages are plausible, ranging from positive to negative. On one hand, antibiotics reduce the availability of hosts and may compromise a bacteria's performance at producing virus particles (Brock 1962) . On the other hand, phages may take advantage of some of the bacterial genetic or phenotypic changes induced by antibiotics, which could enhance their replication (Comeau et al. 2007; Kamal and Dennis 2015) . The latter is manifested in phage-antibiotic synergy (PAS).
Phage-Antibiotic Synergy is the capacity of sub-lethal antibiotic doses to increase phage plaque size and productivity. In vitro and in vivo assays have shown that antibiotics may be associated with higher phage efficacy in decreasing bacterial density (Ryan et al. 2012; Kamal and Dennis 2015) . Although the underlying mechanism of PAS still needs clarification, the experiments by Comeau and collaborators (Comeau et al. 2007) suggest that some antibiotics may increase the efficiency of lysis by phages due to bacterial elongation and associated cell wall weakness. Although the PAS effect has been demonstrated for many bacteria-phage associations, the studies are typically conducted over only a few hours of exposure with a limited range of experimental combinations and conditions. Several gaps exist in our knowledge of the interactions between phages, bacteria and antibiotics. First, phage features such as growth rate, infectivity and burst size, may change in the presence of antibiotics (Cairns et al. 2017) . This is relevant because phage fitness, for example, may be associated with therapeutic performance at clearing the targeted bacteria, or to phage population dynamics in natural environments (Lindberg, McKean and Wang 2014) . Second, scarcely any study has included antimicrobial molecules as a factor influencing phagebacterial interactions beyond the short-term perspective. This is surprising, since intense efforts have been made in the study of long co-evolutionary dynamics between phages and bacteria, which typically require tens or hundreds of bacterial generations to be accurately measured (Avrani and Lindell 2015; Scanlan, Hall and Buckling 2017; Gurney et al. 2017) . Finally, antibiotic resistance research is starting to consider the impact of antibiotics on the natural enemies of bacteria (i.e. phages) (e.g. AriasSánchez et al. 2016; Enault et al. 2017) . In these latter studies, aspects such as the relative importance of phages in transferring antibiotic resistance genes between bacteria or the capacity of resistant bacteria to cope with phages have been explored, but the fate of phages exposed to antibiotics is mostly unknown.
In this study, we evaluate how antibiotics affect phages targeting the bacterium Pseudomonas aeruginosa. This species is an opportunistic pathogen responsible for serious nosocomial infections and highly resistant to many antibiotics (Potron, Poirel and Nordmann 2015) . We aim at evaluating short (2 days) and longer (8 days) term effects of antibiotics on phages. To uncover specific effects of the combinations, we use diverse phage and antibiotic types. We focus on three relevant phage parameters. (i) Phage density over time, measured as the production of viable viral particles or titre. (ii) Phage:bacteria ratio or MOI (multiplicity-of-infection), a biologically relevant concept that relates the number of phages with the availability of bacteria (Abedon 2016) . In general, phages are likely to be effective at limiting bacteria if the former's density increases in conjunction with decreases in the latter (Levin and Bull 2004; Abedon 2016) . (iii) We also evaluate the impact of antibiotics on phage virulence over time. Phage virulence is employed here as the percent reduction in ancestral bacterial population density due to the phage (see also Messenger, Molineux and Bull 1999) . Measuring phage virulence is very informative for estimating the therapeutic potential and co-evolutionary aspects in the interaction between phages and bacteria (Mirzaei and Nilsson 2015) . We predict that different antibiotics may have different effects on the phage parameters studied, which may be specific to the time frame analysed.
MATERIALS AND METHODS

Bacteria and phages
We used the bacterial strain Pseudomonas aeruginosa PAO1 and the phages LKD16, LUZ7, 14/1 and EL (Ceyssens et al. 2006a,b) . We examined these four different phages, employing several types of bacterial receptors and representing different viral families (Table 1) . Phage stocks were prepared by adding 10% vol/vol chloroform to phage-containing bacterial cultures, vortexing and centrifuging. Supernatants containing phages were carefully recovered and stored at 4
• C. The complete protocol has been described elsewhere (Betts et al. 2013) . The stocks were tittered and used as the ancestral phages (T0).
Culture conditions
All experiments were carried out in 24-well plates with a total volume per well of 1500 μL of M9 Minimal Medium supplemented with 100 g/L casamino acids and 200 g/L glucose (MM+) at 37 o C. M9 medium was used for dilutions. The antibiotics tested belong to the following families (bacterial pathways targeted are indicated): ß-lactam (inhibits cell wall synthesis); fluoroquinolone (interferes with nucleic acid synthesis) and macrolide (blocks protein synthesis). The specific antibiotics used, associated to those families, were ceftazidime, ciprofloxacin and erythromycin (Sigma-Aldrich). Antibiotic and phage doses were individually adjusted to inhibit bacterial growth of an untreated control by 40% after 24 h. Specifically, we used: 23 μg/mL of ceftazidime, 60 ng/mL of ciprofloxacin and 145 μg/mL of erythromycin; 560.4 × 10 6 pfu/mL of phage EL, 0.942 × 10 6 pfu/mL of phage LUZ7, 0.410 × 10 6 pfu/mL of phage LKD16 and 0.006 × 10 6 pfu/mL of phage 14/1. Antibiotic doses correspond to half the minimum inhibitory concentration (0.5 MIC). These moderate effects allowed us to study phage and bacterial population dynamics over time without many extinctions. Further, the PAS phenomenon is typically observed at sublethal doses of antibiotics, and synergistic effects of decreasing bacterial density in combined treatments (phage-antibiotics) 
Experimental evolution
Six microcosms with 6 mL of MM+ were inoculated with individual clones of P. aeruginosa PAO1 and incubated overnight (O/N) with constant shaking at 200 rpm. Each population's optical density at 600nm (OD 600 nm ) was adjusted to 0.05 (in 1500 μL of MM+ total volume) as measured in a spectrophotometer (Fluostar, BMG LABTECH). The six replicate populations of each treatment were distributed in six 24-well plates containing 1500 μL of MM+, for a total of 144 populations (6 replicates × 3 antibiotics × 4 phages × 2 (antibiotic presence or absence)). Three replicates per plate with non-treated bacteria (positive controls) were also established (3 replicates × 6 plates: 18 populations). Negative controls with media only were distributed in all plates to monitor for the occurrence of possible contamination. In the experimental evolution protocol, plates were submitted to an intermittent agitation regime to allow phage attachment and adsorption to the bacteria and reduce biofilm formation: 30 seconds at 200 rpm every 30 minutes. Bacterial density (as OD 600 nm ) was measured every day for eight consecutive days. Every 2 days, a volume corresponding to c. 3% of each population was calculated and transferred to minimize possible bottleneck. Each well was homogenized by successive pipetting to disrupt bacterial biofilms before transferring each population into a new well. Wells contained either fresh media with or without antibiotics, but no new phages were added. After transfer, the remainder of the microcosm was stored in 20% glycerol at −80 o C for further analysis. To summarize, we performed a total of three transfers in an 8-day experiment, recording bacterial density by OD 600 nm daily. At transfer 1 (T1), after the transfer but before the addition of glycerol, and in the final populations (T4), 500 μL of the populations containing phages were used to extract phages as described before.
Phage density and MOI
To assess phage density during the evolution experiment, phages extracted at T1 and T4 were added to ancestral bacteria (T0) and the number of infective particles (titer) or phage plaque forming units (pfu/mL) produced in solid media counted. We used T0 bacteria since all treatments had these in common, and evolved phages were likely to produce progeny on them (Hall et al. 2011) . Dilutions and replicates were used as recommended before for this classic microbiology method (Kutter and Sulakvelidze 2004). MOI was calculated as the ratio of the number of virus particles (pfu/mL) to the density of bacteria (OD 600 nm ). The OD 600 nm values were multiplied by 10 7 to normalise the very different scales of the two variables.
Phage virulence
Phage virulence was measured as the capacity to inhibit ancestral bacterial density. Specifically, after titering all phages (T0, T1 and T4), 5000 pfu of each were used to inoculate T0 bacterial cultures. Bacteria density had been adjusted to OD 600 nm 0.05 after previous O/N pre-culture. Change in OD 600 nm of bacterial cultures in the presence of the different phages relative to an uninfected control culture was measured after 24h. Phage virulence as employed here is negatively correlated with OD 600 nm . For this test, we did not include phages exposed to ß-lactams as the populations of T4 phages were too low to attain the 5000 pfu necessary to observe a potentially significant effect.
Bacterial antibiotic resistance level
The level of antibiotic resistance selected by the various treatments is an important factor to consider the long-term efficiency of a strategy aimed at controlling bacteria. This assay was performed only with macrolides and fluoroquinolones evolved bacteria, as all of the ß-lactam exposed replicates were extinct at T4. Bacteria collected at day 8 (T4) were compared to the ancestral ones (T0). Each bacterial replicate was inoculated into MM+ and cultured O/N. OD 600 nm was adjusted to 0.05 into fresh media containing relevant concentrations of antibiotics to determine the MIC after 24h of culture, as described elsewhere (Andrews 2001) . Relative MIC values increasing at a two-fold rate (e.g. 0, 1, 2 and 4, corresponding to 0, 60, 120 and 240 ng/mL of ciprofloxacin, respectively) were assigned to the antibiotic concentrations to establish comparable MIC ranks between the two antibiotics. Ancestor bacteria had a relative MIC of 2, corresponding to 290 μg/mL and 120 ng/mL concentrations of erythromycin and ciprofloxacin, respectively.
Statistical analysis
Linear mixed models (LME) including random factors or General Linear Models (GLM) and ANOVA were used for most analysis. When analysing the differences in phage densities over time, and for standardisation purposes, we compared T1 or T4 densities with the initially inoculated densities (T0), by dividing the former by the latter. In the models to test overall effects, phage density, MOI or phage virulence were included as response variables. Fixed predictor variables were time (i.e. transfer), antibiotic presence/absence or phage presence/absence. To take into account the non independence of data points belonging to the same phage or antibiotic type, or of an individual population (biological replicate) measured repeatedly through time, these variables were considered as random effects. In the models testing the specific effects of the different phage and antibiotic types, these were considered as fixed predictor variables, while testing the same response variables. Individual populations were maintained as a random effect. In each model, all interactions between fixed predictor variables were included and model reduction performed by removing non-significant interactions (P > 0.05). Tukey post hoc tests were performed to consider all possible pairwise comparisons in the phage virulence assay (for example: virulence of T1 phage evolved with antibiotics versus T4 phage evolved without antibiotics). For the analysis of MIC values, non-parametric tests using the calculated medians of the MIC ranks were performed. R software was used for the analysis.
To improve visualisation, phage density and MOI data were logarithmically transformed (Figs 1 and 2) . Specifically, log (x+1) was used, in order to avoid non valid or negative values in the logarithmic calculation. Relative phage virulence was calculated as the effect of the evolved phages (T1, T4) on ancestral bacterial density (measured as OD 600 nm ), divided by the effect of the T0 phages (Fig. S3 , Supporting Information).
RESULTS
Antibiotics negatively affect the density of phages in the short, but not in the longer term
When measuring phage density over time, we observed that the initial density (T0) increased after 2 days of culture (T1), especially in non-antibiotic treatments (LME antibiotic: F 1,95 = 57.376; P < 0.0001; Fig. 1, Supplementary Fig. S1 ). Six days later (T4), phage density decreased and was not statistically significantly different from the initially inoculated samples (T0), regardless of the presence of antibiotics (LME time: F 1,99 = 0.106; P = 0.744; LME antibiotic: F 1,99 = 0.075; P = 0.784; Fig. 1; Fig. S1 , Supporting Information). This result suggests either phage adaptation to antibiotic treatments or that the bacteria are adapting to phages and antibiotics.
We observed differences between antibiotic types in their effects on phage density, as well as significant differences between phage types, the interaction between phage and antibiotic type, and the time point analysed (LME antibiotic types: F 3,186 = 23.730; P < 0.0001; phage types F 3,186 = 27.306; P < 0.0001; phage × antibiotic F 9,186 = 59.564; P < 0.0001; phage × time F 3,186 = 20.010; P = 0.0002; antibiotics × time F 3,186 = 22.811; P < 0.0001). Specifically, fluoroquinolones did not decrease the density of phages compared to non-antibiotic conditions, as did the macrolides or ß-lactams (Fig. 1) . For this last antibiotic, phages and bacteria were practically extinct in phageantibiotic treatments. Phage 14/1 attained the highest density alone and in most antibiotic combinations, and phage EL the lowest (Fig. 1) . Receptor type, phage family and co-evolutionary dynamic type were considered as factors in the analysis, but no relevant patterns were extracted. In sum, most antibiotics negatively affected phage density early on but none did in the longer term. These results contrast with previous work showing that antibiotics increase phage yield, at least in the short-term (e.g. Comeau et al. 2007; Ryan et al. 2012 ).
Antibiotics increase the ratio of phages to bacteria (MOI) during evolution
We analysed the MOI or ratio of phage to bacterial densities through time, in the presence or absence of antibiotics, as an estimate of antibiotic impact on phage production. Even if phage concentrations were reduced in antibiotic environments at T1 relative to non-antibiotic conditions, bacterial population densities were also affected (see Results section 4). Under nonantibiotic conditions, bacteria were, logically, much more abundant than in antibiotic environments (see Results section 4). The MOI differed between treatments, being higher in the presence of antibiotics compared to in their absence (LME antibiotic: F 3,94 = 9.422, P = 0.0242, Fig. 2; Fig. S2, Supporting Information) . However, these differences were significant for T1 phages but not for those at T4 (LME time: F 3,183 = 8.387, P = 0.0387). At T4 the MOI was reduced compared to T1 as a consequence of low phage densities at T4, but similar in all treatments ( Fig. 2; Fig. S2 , Supporting Information). Equal MOI between treatments in the longer term could be a sign of phage adaptation to antibiotics.
Phage types resulted in significantly different MOI (LME phage types: F 3,183 = 12.513; P = 0.0058), with phage 14/1 reaching the highest MOI at both time points. Antibiotic had a significant effect on the MOI at T1 but not at T4, with fluoroquinolones showing a significantly more pronounced effect (LME antibiotic types: F 3,183 = 2.117; P = 0.0343; Fig. 2 ) As before, no relevant patterns were detected regarding phage receptor and other characteristics. Overall, these results suggest that, at least transiently, fluoroquinolones are associated with greater phage productivity than the other antibiotics tested.
Phage virulence is transiently affected by antibiotics
The effect of ancestral (T0) and evolved (T1, T4) phages on ancestral bacterial (T0) density was used as a measure of phage virulence. Early on, evolved phages (T1) decreased ancestral bacterial density less than did ancestral phages (T0) (LME time: F 1,96 = 10.571, P < 0.0011; Fig. 3 ). This decrease in phage virulence is unexpected and contrasts with our estimates of phage density and MOI. The presence of antibiotics during the evolution regime decreased phage virulence even more (LME antibiotic: F 1,96 = 10.129, P = 0.0015). Here, phages evolved with antibiotics did not affect bacterial density when compared to control cultures not exposed to phage (Tukey: Z 1,96 = −1.194, P = 0.6113; Fig. 3 ). Phage types at T1 had significantly different impacts on ancestral bacterial density (LME phage types: F 3,162 = 12.054, P = 0.0072; Fig. S3 , Supporting Information), with phage LKD16 having the largest negative impact and phage EL the weakest. Antibiotic types produced significantly different effects on the virulence of phages at T1 (ANOVA antibiotic types: F 2,71 = 5.019, P = 0.0097; Fig. S3 , Supporting Information), with fluoroquinolones increasing phage virulence more than macrolides. Finally, there was a significant effect of different phage-antibiotic combination on T1 phages virulence (LME phage type × antibiotic type interaction: F 6,71 = 16.751, P = 0.0102; Fig. S3 , Supporting Information).
Phages evolved for 8 days (T4) had increased virulence compared to T1 phages (LME time: F 1,96 = 118.275, P < 0.0001; Fig. 3 ), but not higher than T0 phages (Tukey: Z = −1.803, P = 0.2531). Antibiotics did not have a significant effect on phage virulence at T4 (ANOVA antibiotic: F 2,78 = 2.799, P = 0.0670; Fig. 3 ). Here, phage types did not differ in phage virulence (ANOVA phage types: F 2,78 = 1.538, P = 0.2110; Fig. S3 , Supporting Information), but antibiotic types did (ANOVA antibiotic types: F 2,60 = 4.317, P = 0.0180; Fig. S3 , Supporting Information). Specifically, macrolides had a negative or neutral effect on phage virulence (compared to non-antibiotic treated phages) and fluoroquinolones a positive or neutral effect (Fig. S3, Supporting Information) . Phage classification (receptor type, etc) was not significant for phage virulence either. Altogether, we observed changes in phage virulence through time (which are different in the presence of antibiotics) that suggest (co)-evolutionary dynamics in these phage-bacteria populations. Importantly, antibiotics negatively affected T1 phage virulence, but phages appeared to overcome this constraint and recovered virulence in the longer time frame.
Combined treatments better control bacterial density and antibiotic resistance evolution
In the first 2 days of the experiment (T1), phages and antibiotics had the same effect at inhibiting bacterial densities when added separately (OD 600 nm = 0.746 ± 0.1670) (Fig. 4A) , as expected by fitting the initial phage density and antibiotic dose in order to reduce a non-treated culture density by 40%. In combined treatments, bacterial density was dramatically limited in the first 2 days (OD 600 nm = 0.148 ± 0.0150), corresponding to a decrease of more than 80% relative to the density of the control culture. Regardless of treatment, all bacterial densities increased progressively over the 8 days of the experiment (Fig. 4A) .
The statistical analysis confirmed that combined treatments had the highest effect in limiting bacterial populations (LME treatment (same categories as in Fig. 4A ): F 1,42 = 54.522, P < 0.0001; General Linear Model phage presence in antibiotic treatments: F = −0.218, P < 0.0001; Fig. 4A ). This bacterial density difference was observed until day 3 (GLM phage presence in antibiotic treatments at day 3: F 1,42 = −2.049, P = 0.0435). However, from day 4, bacterial densities did not differ between single antibiotics or combined treatments (e.g., GLM phage presence in antibiotic treatments of day 8: F 1,42 = −0.147, P = 0.1950). We also used the mean of the cumulative bacterial density over time, to simplify the data set (Fig. S4, Supporting Information) . Different antibiotic and phage types produced different effects, and each combination of antimicrobial agents was significantly different from one another (Fig. S4, Supporting Information) . In both single and combined treatments, ß-lactams had the strongest negative effects on bacterial density (LME antibiotic types: F 3,128 = 1370.93, P < 0.0001, Fig. S4, Supporting Information) , to the point of driving bacteria to extinction in combined treatments. LKD16 was the most effective phage at decreasing bacterial densities alone or in combination (Fig. S4, Supporting Information) . EL phage in the absence of antibiotics did not have any effect (LME phage types: F 4,128 = −0.0650, P = 0.2501). In combination with antibiotics, EL had a smaller negative impact on bacterial density compared to the other phage types (Fig. S4 , Supporting Information).
Antibiotic resistance (MIC) in bacteria collected at T4 increased compared to T0 levels for some but not all antibiotic types, but combination with phages limited this resistance (Fig. 4B) . This was particularly clear for fluoroquinolone antibiotics (Kruskal-Wallis antibiotic: chi-squared = 23.79, df = 1, P < 0.0001; combination or single treatment: chi-squared = 16.091, df = 1, P < 0.0001). Phage types did not affect fluoroquinolone resistance differently (Kruskal-Wallis phage types: chi-squared = 2.5426, df = 3, P = 0.4676; data not shown). Surprisingly, resistance to macrolides did not change in T4 macrolide-treated bacteria compared to the ancestor (T0) (Kruskal-Wallis macrolide treatment: chi-squared = 3.4626, df = 1, P = 0.063; combination or single treatment: chi-squared = 3.2003, df = 1, P = 0.0740). However, phage type emerged as a significant factor determining resistance in T4 bacteria (Kruskal-Wallis phage types: chisquared = 10.255, df = 3, P = 0.0165; data not shown). For example, treatments including the phage EL surprisingly selected for higher macrolide MIC values than in the absence of phage (data not shown). Phage virulence represented as the effect on density of ancestor bacteria (T0) compared to a control (T0 bacteria not exposed to phages). Values correspond to mean OD600 nm of bacteria exposed or not to phages (6 replicates per treatment). Phages tested were ancestor (T0) and evolved (T1 and T4) under different antibiotics or not ("+Ab" and "-Ab" respectively). All antibiotic and phage types are merged together. Error bars represent standard errors.
DISCUSSION
We experimentally investigated the effects of antibiotics on phages in the context of combined therapies. Beneficial effects of antibiotics on some phage parameters (e.g. plaque size and in vitro and in vivo efficacy) have been described before, particularly with respect to sub-lethal doses of certain families of antibiotics such as ß-lactams (Comeau et al. 2007; Kamal and Dennis 2015) . We did not observe these favourable effects and, importantly, several of our results indicate the opposite: antibiotics decrease both phage density and virulence shortly after their introduction (2 days). In contrast, later in the experiment (8 days), antibiotics did not have a distinguishable impact on phages, possibly due to the capacity of phages to adapt.
Our results indicate that the impacts of antibiotics on phages, and the combined impact of phages and antibiotics on bacteria, can change considerably as the interactions progress. We examined interactions over time scales longer than in most PAS studies (up to 8 days compared to a few hours) (e.g. Kamal and Dennis 2015; Scanlan, Bischofberger and Hall 2017) . In addition, differences in experimental design must also be considered, such as the frequency at which the substrate is renewed, which affects bacterial growth dynamics and adaptation to the phages (e.g. continuous culture used by Kirby 2012, compared to serial transfers used by . A recent exceptionally long (66-days) study found that streptomycin was detrimental to P. fluorescence φ2 phage (Cairns et al. 2017) . Moreover, these authors found that phage presence in antibiotic environments increased antibiotic resistance, a result contrary to the present study and other previous studies (Zhang and Buckling 2012; .
We chose to measure phage density rather than influential traits such as adsorption rate and burst size, because the former measure has been shown to correlate with therapeutic performance in vivo (Lindberg, McKean and Wang 2014) . Moreover, phage densities and their association with bacterial densities (MOI) are relevant ecological parameters. A regulation of phage production depending on the MOI has been previously shown in natural communities. For example, phage densities and mean burst sizes were lower with decreasing proportion (i.e. MOI) of the host Aureococcus anophageffrens (Brown and Bidle 2014) . The authors suggested that high MOI both reduces the impact of viruses and their host, and results in ineffective viral production. Interestingly, we observed that achieving a higher titre during evolution is not always associated with the capacity of those phages to decrease the density of ancestral bacterial cells, at least in vitro. In other words, T1 phages are very efficiently multiplied in bacteria but do not have substantial impacts on their density. Conversely, T4 phages are able to limit the density of T0 bacteria effectively but produce few progeny. Although clearly demonstrated in vitro, it is unknown to what extent bacterial and viral population densities are affected by antibiotics in nature. Focusing on the impact of antibiotics on phages is important in understanding the outcomes of combined therapies. As demonstrated, antibiotics had an initial negative effect on phages that was later overcome. We suggest that burst size, adsorption or other phage life history traits may have evolved in our experimental setting.
Fluoroquinolones improved or were neutral to the studied phage parameters compared to the negative effects recorded when using ß-lactam or macrolide antibiotics. At the mechanistic level, this is consistent with previous findings pointing to a beneficial effect of the elongated cell morphology induced by fluoroquinolone antibiotics (Comeau et al. 2007 ). An important outcome is that the combination of fluoroquinolones with phages limited the evolution of antibiotic resistance. ß-lactam antibiotics did not improve phage capabilities as expected, but the advantage regarding bacterial density control appeared decisive. Macrolide antibiotics, targeting protein synthesis, seemed to negatively interfere with phages. One possibility is that antibiotics damage phages directly, an effect that has been observed for other antibiotics binding ribosome subunits (streptomycin) (Brock 1962 ). An alternative (or complementary) is that this effect is due to damage to a bacterial core function. Based on our findings and previous work, we suggest that the physiological effects of antibiotic-exposed bacteria are more important for phages than are demographic effects (Torres-Barceló and Hochberg 2016). More research is needed to evaluate this proposal.
Regarding phage types, the Myoviridae 14/1 and the Podoviridae LKD16 reached the highest titres, MOI and virulence. Betts and colleagues (2014) previously showed that phage 14/1 exhibited arms race dynamics (ARD: where evolving phages/bacteria are progressively able to better infect/resist past populations) with its host (Betts, Kaltz and Hochberg 2014) . Phage LKD16 on the other hand showed fluctuating selection dynamics (FSD: where there is no temporal trend in infectivity or resistance). We found no evidence that differences in virulence of the phages analysed in this work were associated with the type of coevolutionary dynamic. Both the ARD phage (14/1) and the FSD phage (LKD16) showed high virulence.
Our findings indicate how the choice of antimicrobials and the time scales of their action can have important consequences for the control of pathogenic bacteria. Combining fluoroquinolones or ß-lactams with either of these two phages (14/1 and LKD16) could result in the effective control of P. aeruginosa infections, coupled with antibiotic resistance limitation. However, our results indicate that the outcome of a therapy could depend on the time scale. Importantly, early in the interaction between phage and bacteria, sub-lethal doses of antibiotics can interfere with phage virulence. Such combinations should be avoided if bacterial control over short time scales is a decisive factor in therapeutic success. This could be relevant to the treatment of some bacterial infections in situ, where adaptive and innate immune systems are expected to contribute to clearing the infection (Hodyra-Stefaniak et al. 2015; Roach et al. 2017) . The scale of several days or more, are the time scales necessary for immune responses to contribute to bacterial pathogen suppression. Future theoretical and experimental studies should integrate ecological and evolutionary interactions over time scales comparable to the duration of an infection under treatment, including the actions of innate and adaptive immune responses (e.g., Ankoma and Levin 2014; Hochberg 2017) . Nevertheless, we found that short-term limitations did not necessarily affect the longer-term performance of combined introductions. We suggest that increased attention should be given to ecological and evolutionary interactions over time scales comparable to the duration of an infection under treatment.
Finally, our results are also relevant regarding the possibility of 'training' phages for therapy. This method consists of either repeatedly passaging phages on samples of the ancestral bacterium to be targeted (Betts et al. 2013) , or serially co-evolving the two antagonists (Betts, Kaltz and Hochberg 2014) . After this short evolution, the recovered ("trained") phages are expected to be more efficient at killing their host and will be used in the applied cocktails (Betts et al. 2013) . The results of our study indicate that co-evolutionary training of phages in vitro in the presence of antibiotics could lessen their impact at least initially, when reintroduced to control bacteria in situ. Further study is necessary to test the generality of this result.
